Skip to main content
Clinical Trials/NCT03638102
NCT03638102CompletedNot Applicable

The Effect of Sleep Extension on Glucose Metabolism in Women With Previous Diagnosis of Gestational Diabetes

University of Illinois at Chicago1 site in 1 country18 target enrollmentStarted: February 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
18
Locations
1
Primary Endpoint
Changes in Fasting Glucose

Study Overview

Brief Summary

Women with a history of gestational diabetes (GDM) are at high risk of developing diabetes in the future. Sleep disturbances are emerging as risk factors for incident diabetes. The purpose of this study is to test the effects of 6-week sleep extension in women with a history of GDM and short sleep on glucose metabolism by randomized controlled study.

Detailed Description

The primary aim of this study is to evaluate the effects of a sleep extension intervention in non-diabetic women with a prior history of GDM and habitual short sleep duration on the outcomes of glucose metabolism. The participants will be randomized to a 6-week sleep extension intervention group, using technology-assisted sleep intervention, or a healthy living information control group. Glucose metabolism parameters will be assessed by an oral glucose tolerant test.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Premenopausal women, age 18-45, with a history of GDM who currently do not have diabetes
  • •At least one year post-partum
  • •Reported habitual sleep duration <7h/night during work- or weekdays with a desire to sleep longer
  • •Reported time spent in bed =<8 hours
  • •Own a smartphone compatible with Fitbit.
  • •No need to provide care at night for her child(ren), defined as >3 times a week and >30 minutes at a time
  • •No history of obstructive sleep apnea, insomnia, or restless leg syndrome

Exclusion Criteria

  • •A1C ≥6.5%
  • •Currently pregnant or planning pregnancy or breast feeding
  • •Insomnia symptoms defined as severe as assessed by the Insomnia Severity Index (score ≥15)
  • •Rotating shift or night shift work
  • •High risk for obstructive sleep apnea screened by STOP BANG questionnaire.
  • •Significant medical morbidities, such as congestive heart failure, cirrhosis, chronic obstructive pulmonary disease requiring oxygen, active treatment for cancer or psychiatric problem, history of stroke with neurological deficits, cognitive impairment, kidney failure requiring dialysis, illicit drug use.

Arms & Interventions

Sleep intervention

Experimental

Sleep extension

Intervention: Sleep extension (Behavioral)

Healthy living

Active Comparator

Health education

Intervention: Healthy living (Behavioral)

Outcomes

Primary Outcomes

Changes in Fasting Glucose

Time Frame: 6 weeks

Changes in fasting glucose between baseline and 6 weeks

Sleep Duration Change

Time Frame: baseline and 6 weeks

Changes in sleep duration from baseline to 6 weeks

Secondary Outcomes

  • HOMA-IR Change(baseline and 6 weeks)
  • Change in Subjective Sleep Quality(Baseline and week 6)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sirimon Reutrakul

Associate Professor

University of Illinois at Chicago

Study Sites (1)

Loading locations...

Similar Trials